We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current IDRSF market cap is 188.57M. The company's latest EPS is CHF -1.3987 and P/E is -0.71.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Revenue | 71.76M | 35.35M | 97.1M | 152.39M | 112.51M |
| Operating Income | -410.58M | -613M | -802.96M | -560.24M | -357.34M |
| Net Income | -444.79M | -634.6M | -827.9M | -297.92M | -263.76M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Assets | 1.44B | 1.48B | 904.18M | 500M | 505.9M |
| Total Liabilities | 849.88M | 1.38B | 1.57B | 1.47B | 1.72B |
| Total Equity | 585.48M | 104.2M | -660.96M | -968.72M | -1.21B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Operating | -364.67M | -589.9M | -859.11M | -629.3M | -370.23M |
| Investing | -607.13M | -53.26M | 743.9M | 632.61M | 305.06M |
| Financing | 850.08M | 604.15M | 162.31M | -197k | 26.11M |
| Market Cap | 188.57M |
| Price to Earnings Ratio | -0.71 |
| Price to Sales Ratio | 1.68 |
| Price to Cash Ratio | 1.77 |
| Price to Book Ratio | -0.16 |
| Dividend Yield | - |
| Shares Outstanding | 188.57M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 1.33k |
| 52 Week Change | -52.38% |
| 52 Week High | 2.88 |
| 52 Week Low | 0.70 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Idorsia AG (CE) |
| Address |
hegenheimermattweg 91 allschwil 4123 |
| Website | https://www.idorsia.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
